These findings are consistent with Abreu et al., who showed that TIMP1-deficient breast cancer cells had lower proliferation rates in vivo, both in zebrafish embryos and orthotopic xenografts in immunosuppressed mice [48]. This evidence concerns the gene TIMP1 and breast cancer.